Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Marimed Inc (OP: MRMD )

0.2485 -0.0015 (-0.60%)
Streaming Delayed Price Updated: 11:40 AM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Marimed Inc

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Cannabis Stock Gainers And Losers From March 19, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Here's Where To Buy Legal Weed: New Stores Launching Cannabis Sales Ahead Of 4/20, Part 1
Cannabis sales in Illinois seem to be thriving. In 2023, the licensed cannabis retailers sold more than $1.6 billion worth of cannabis, marking the third consecutive year of substantial growth in this... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Monday For Marijuana Stocks - Greenlane Hldgs, Heritage Cannabis Holding Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
MRMD Stock Earnings: MariMed Beats Revenue for Q4 2023
MRMD stock results show that MariMed beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Cannabis Chart Of The Week: The Market Reacted Rationally (For A Change) To 4th Qtr 2023 Earnings Releases
Earnings for the 4th quarter of 2023 have largely been released, and the results were generally positive, with a few exceptions. Unlike what we expected, the market reacted rationally to the EBITDA... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For March 15, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From March 14, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
MariMed's Earnings: A Preview
Via Benzinga
MariMed Wholesale Revenue Up 48% Driven By Top Marijuana Brands: Why Is This Weed Stock Undervalued?
MariMed Inc. (OTC: MRMD), a notable player in the US cannabis market, recently reported its financial results and forward-looking guidance, revealing strategic moves to navigate the sector's evolving... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From March 12, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For March 11, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For March 8, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
MariMed Reports 'Another Year Of Strong Operational And Financial Performance' And More To Come In 2024
We had a record year with respect to revenue generation, particularly in wholesale, new asset openings and leveraging our balance sheet strength to secure capital," said Jon Levine, MariMed's CEO. 
Via Benzinga
Cannabis Stock Movers For March 6, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From March 4, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
U.S. Cannabis Council Teams Up With Curaleaf On National Donation Drive For Legalization
Curaleaf and the U.S. Cannabis Council unite for a groundbreaking donation drive to propel cannabis legalization efforts nationwide. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For February 21, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Overweight Rating Highlights Jushi Holdings' Market Edge: Weed Stock Valuation Gap Analysis
Zuanic & Associates gave Jushi Holdings Inc. (CSE: JUSH) (OTC: JUSHF) an Overweight rating as the firm begins its coverage of the marijuana company. 
Via Benzinga
Cannabis Stock Gainers And Losers From February 20, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From February 13, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For February 12, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For February 7, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From February 5, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For February 2, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
A Top Weed Stock Under The Radar: Strong Growth, Cash Flow Savings And Low-Value Market Position
Zuanic & Associates' senior analyst Pablo Zuanic offers a detailed analysis of MariMed Inc. (OTC: MRMD), underscoring its promising trajectory in the cannabis sector and its potential to become a top... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For January 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
US Cannabis Stocks Surge By 69%: Water Tower Research Report Breaks Down Top Performers
In a recent report from Water Tower Research, authored by analyst Jesse Redmond, the cannabis industry's current landscape paints an interesting, if optimistic, picture. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
2024 Oscars Of Marijuana Equity: Analyst Nominations Spotlight Key State Performers
In his latest cannabis sector equity report, senior analyst Pablo Zuanic of Zuanic & Associates offers a detailed examination of the cannabis sector's landscape in the fourth quarter of 2023. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For January 22, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For January 19, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.